Literature DB >> 20489682

Eye-care utilization among women aged > or =40 years with eye diseases--19 states, 2006-2008.

.   

Abstract

Diabetic retinopathy (DR), glaucoma, and age-related macular degeneration (ARMD) are major causes of vision loss and blindness. Women have been found to have a higher prevalence of vision loss than men. Early detection and timely treatment by eye-care providers are necessary to delay disease progression and prevent vision loss. To assess the use of professional eye care among women aged > or = 40 years, CDC analyzed data from the Behavioral Risk Factor Surveillance System (BRFSS) for 19 U.S. states for the period 2006-2008. This report summarizes the results of that analysis, which indicated that 21% of women with self-reported DR, 12% of women with self-reported glaucoma, and 8% of women with self-reported ARMD did not visit an eye-care provider in the recommended follow-up period. Women who did not have insurance coverage for eye care or who did not receive routine medical check-ups were more likely to report not having the recommended follow-up eye care. The two most commonly cited reasons for not having an eye-care visit were cost or not having insurance (range across diseases: 40%-46%) and having no reason to go for follow-up (range: 20%-29%). Compliance with obtaining eye examinations at recommended intervals among women aged > or = 40 years with eye diseases might be enhanced by improving access to health care and implementing and expanding existing educational programs to raise awareness regarding the importance of routine follow-up eye examinations.

Entities:  

Mesh:

Year:  2010        PMID: 20489682

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Economic inequality in eye care utilization and its determinants: a Blinder-Oaxaca decomposition.

Authors:  Mohammad Hassan Emamian; Hojjat Zeraati; Reza Majdzadeh; Mohammad Shariati; Hassan Hashemi; Akbar Fotouhi
Journal:  Int J Health Policy Manag       Date:  2014-10-13

2.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

3.  Eye care use among a high-risk diabetic population seen in a public hospital's clinics.

Authors:  Paul A Maclennan; Gerald McGwin; Christine Heckemeyer; Virginia R Lolley; Sandral Hullett; Jinan Saaddine; Sundar S Shrestha; Cynthia Owsley
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

4.  Association of Sex With the Global Burden of Cataract.

Authors:  Lixia Lou; Xin Ye; Peifang Xu; Jingyi Wang; Yufeng Xu; Kai Jin; Juan Ye
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

5.  A Retrieval System for Patients with Avoidable Blindness Due to Diabetic Retinopathy who do not Present for Ophthalmic Assessment in Oman.

Authors:  Rajiv Khandekar; Jawad Al Lawati; Nabil Barakat
Journal:  Middle East Afr J Ophthalmol       Date:  2011-04

6.  Prevalence and Factors Associated with the Use of Eye Care Services in South Korea: Korea National Health and Nutrition Examination Survey 2010-2012.

Authors:  Yong Seok Park; Hwan Heo; Byeong Jin Ye; Young-Woo Suh; Seung-Hyun Kim; Shin Hae Park; Key Hwan Lim; Sung Jin Lee; Song Hee Park; Seung-Hee Baek
Journal:  Korean J Ophthalmol       Date:  2017-02-02

7.  Assessment of Horizontal Inequity in Eye Care Utilization in the Iranian Middle-aged Population.

Authors:  Maedeh Raznahan; Mohammad Hassan Emamian; Hassan Hashemi; Hojjat Zeraati; Akbar Fotouhi
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

8.  A survey of Alabama eye care providers in 2010-2011.

Authors:  Paul A Maclennan; Gerald McGwin; Karen Searcey; Cynthia Owsley
Journal:  BMC Ophthalmol       Date:  2014-04-03       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.